Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 183,452 | -47,579 | -284,232 | -293,654 | -290,023 |
| Depreciation Amortization | 676 | 1,012 | 4,869 | 12,223 | 17,291 |
| Accounts receivable | -2,543 | -6,737 | 3,433 | 765 | 25,180 |
| Accounts payable and accrued liabilities | -27,654 | 14,512 | -15,514 | 5,909 | 805 |
| Other Working Capital | -153,032 | -117,459 | -119,687 | 70,430 | 60,083 |
| Other Operating Activity | -5,673 | 18,252 | 96,110 | 58,394 | 104,432 |
| Operating Cash Flow | $-4,774 | $-137,999 | $-315,021 | $-145,933 | $-82,232 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -61,158 | -8,628 | -245,101 | -156,641 | -479,930 |
| PPE Investments | -38 | 780 | -2,519 | -3,735 | -5,186 |
| Net Acquisitions | 96,615 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | 133,841 | 400,621 | 284,492 | 83,144 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -35,000 | -25,000 |
| Other Investing Activity | 0 | 0 | 656 | -35,000 | -25,000 |
| Investing Cash Flow | $35,419 | $125,993 | $153,657 | $89,116 | $-426,972 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 74,078 | N/A | N/A |
| Debt Repayment | -80,560 | -40 | -484 | -538 | -5,892 |
| Common Stock Issued | N/A | 139 | 52,138 | 4,184 | 12,701 |
| Other Financing Activity | -5,468 | -354 | -2,983 | 43,130 | -7,372 |
| Financing Cash Flow | $-86,028 | $-255 | $122,749 | $46,776 | $-563 |
| Exchange Rate Effect | 1,077 | 751 | -3,397 | -5,482 | 2,597 |
| Beginning Cash Position | 102,178 | 113,688 | 155,700 | 171,223 | 678,393 |
| End Cash Position | 47,872 | 102,178 | 113,688 | 155,700 | 171,223 |
| Net Cash Flow | $-54,306 | $-11,510 | $-42,012 | $-15,523 | $-507,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,774 | -137,999 | -315,021 | -145,933 | -82,232 |
| Capital Expenditure | -38 | -266 | -2,519 | -3,741 | -5,186 |
| Free Cash Flow | -4,812 | -138,265 | -317,540 | -149,674 | -87,418 |